1430744-75-4

Upstream product

• 585-71-7 (1-bromoethyl)benzne 
• 63261-04-1 1-(1-phenylethyl)-1H-benzimidazol-2-amine 
• 934-32-7 1H-benzimidazol-2-amine 

Downstream Products

• 1430745-10-0 C₂₂H₂₃N₅O 
• 1430745-11-1 10-(1-phenylethyl)-2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-one maleate 

Relevant academic research and scientific papers

Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones

The multistep preparation of the new 10-substituted 2-(1-piperazinyl) pyrimido[1,2-a]benzimidazol-4(10H)-ones 6a-o, and of the two isomers 10-ethyl-2-(diethylamino)pyrimido[1,2-a]benzimidazol-4(10H)-one 6p and 10-ethyl-4-(diethylamino)pyrimido[1,2-a]benzimidazol-2(10H)-one 13, as well as the in vitro evaluation of their inhibitory activity on human platelet aggregation induced in platelet-rich plasma by ADP, collagen or the Ca 2+ ionophore A23187 were here described. Nine out of fifteen 2-(1-piperazinyl)derivatives (6g-o) showed good inhibitory properties towards all the platelet aggregation agonists used. Moreover, a molecular modelling study has been performed on two of the best compounds of this series (6i and 6o) to confirm in silico their interactions with the catalytic site of human platelet PDE3, using the X-ray data of the PDE3B isoform in complex with an inhibitor.